Literature DB >> 16810718

Deep brain stimulation: preoperative issues.

Anthony E Lang1, Jean-Luc Houeto, Paul Krack, Cynthia Kubu, Kelly E Lyons, Elena Moro, William Ondo, Rajesh Pahwa, Werner Poewe, Alexander I Tröster, Ryan Uitti, Valerie Voon.   

Abstract

Numerous factors need to be taken into account in deciding whether a patient with Parkinson's disease (PD) is a candidate for deep brain stimulation. Patient-related personal factors including age and the presence of other comorbid disorders need to be considered. Neuropsychological and neuropsychiatric concerns relate both to the presurgical status of the patient and to the potential for surgery to result in new problems postoperatively. A number of factors related to the underlying PD need to be considered, including the specific parkinsonian motor indications (e.g., tremor, bradykinesia, gait dysfunction), previous medical therapies, including benefit from current therapy and adverse effects, and past surgical treatments. Definable causes of Parkinsonism, particularly atypical Parkinsonisms, should be considered. Finally, methods of evaluating outcomes should be defined and formalized. This is a report from the Consensus on Deep Brain Stimulation for Parkinson's Disease, a project commissioned by the Congress of Neurological Surgeons and the Movement Disorder Society (MDS). The report has been endorsed by the Scientific Issues Committee of the MDS and the American Society of Stereotactic and Functional Neurosurgery. It outlines answers to a series of questions developed to address all aspects of deep brain stimulation preoperative decision-making.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16810718     DOI: 10.1002/mds.20955

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  70 in total

1.  Informed Consent in Implantable BCI Research: Identifying Risks and Exploring Meaning.

Authors:  Eran Klein
Journal:  Sci Eng Ethics       Date:  2015-10-23       Impact factor: 3.525

2.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

3.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

4.  Do stable patients with a premorbid depression history have a worse outcome after deep brain stimulation for Parkinson disease?

Authors:  Michael S Okun; Samuel S Wu; Kelly D Foote; Dawn Bowers; Shilpa Gogna; Catherine Price; Irene Malaty; Ramon L Rodriguez; Charles E Jacobson; Herbert Ward
Journal:  Neurosurgery       Date:  2011-08       Impact factor: 4.654

5.  DBS candidates that fall short on a levodopa challenge test: alternative and important indications.

Authors:  Takashi Morishita; Maryam Rahman; Kelly D Foote; Kyle M Fargen; Charles E Jacobson; Hubert H Fernandez; Ramon L Rodriguez; Irene A Malaty; Dawn Bowers; Christopher J Hass; Yoichi Katayama; Takamitsu Yamamoto; Michael S Okun
Journal:  Neurologist       Date:  2011-09       Impact factor: 1.398

6.  Parkinson disease: Neurostimulation in PD--benefit of early surgery revealed.

Authors:  Suneil K Kalia; Andres M Lozano
Journal:  Nat Rev Neurol       Date:  2013-04-16       Impact factor: 42.937

7.  Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.

Authors:  Thomas G Beach; Charles L White; Christa L Hladik; Marwan N Sabbagh; Donald J Connor; Holly A Shill; Lucia I Sue; Jeanne Sasse; Jyothi Bachalakuri; Jonette Henry-Watson; Haru Akiyama; Charles H Adler
Journal:  Acta Neuropathol       Date:  2008-11-04       Impact factor: 17.088

8.  Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Authors:  Nader Pouratian; Sandeep Thakkar; Won Kim; Jeff M Bronstein
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-09-04

Review 9.  The treatment of movement disorders by deep brain stimulation.

Authors:  Hong Yu; Joseph S Neimat
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

10.  Improved subthalamic nucleus depiction with quantitative susceptibility mapping.

Authors:  Tian Liu; Sarah Eskreis-Winkler; Andrew D Schweitzer; Weiwei Chen; Michael G Kaplitt; A John Tsiouris; Yi Wang
Journal:  Radiology       Date:  2013-05-14       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.